INTECH Investment Management’s Bio-Rad Laboratories Class A BIO Stock Holding History

INTECH Investment Management’s Portfolio BIO Stock Details BIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-714	Closed	-$235K	–	2527
2024 Q4	$235K	Buy	+714	New	+$242K	﹤0.01%	1959
2023 Q2	–	Sell	-10,025	Closed	-$4.8M	–	709
2023 Q1	$4.8M	Sell	10,025 -7,275	-42%	-$3.41M	0.04%	379
2022 Q4	$7.27M	Sell	17,300 -1,338	-7%	-$540K	0.05%	335
2022 Q3	$7.77M	Sell	18,638 -4,083	-18%	-$2.04M	0.06%	313
2022 Q2	$11.2M	Buy	+22,721	New	+$11.8M	0.06%	268

Other funds holding BIO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return

VAM

Veritas Asset Management London, United Kingdom $5.56B AUM 3.46% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

INTECH Investment Management's BIO Position: Q1 2025 in Review

INTECH Investment Management sold out of Bio-Rad Laboratories Class A (BIO) in Q1 2025, closing a stake of 714 shares — an estimated $235K sold.

INTECH Investment Management first reported a position in BIO in Q2 2022 and held it in 5 quarters. The position peaked at $11.2M in Q2 2022. 436 funds tracked by Wall St. Rank hold BIO as of Q1 2025.

INTECH Investment Management reported no remaining Bio-Rad Laboratories Class A position as of Q1 2025 after selling out during the quarter.
INTECH Investment Management sold 714 Bio-Rad Laboratories Class A shares in Q1 2025, an estimated $235K.
INTECH Investment Management first reported a position in Bio-Rad Laboratories Class A in Q2 2022 and held it in 5 quarters.
INTECH Investment Management's Bio-Rad Laboratories Class A position peaked at $11.2M in Q2 2022.
436 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q1 2025.

Based on INTECH Investment Management's 13F filing for Q1 2025, filed 20 May 2025.